New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Bone cells suppress cancer metastases

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary
Oncology March 30,2024
Bone cells suppress cancer metastases

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary
Oncology March 30,2024
New drug targets for BRCA-driven cancer uncovered

New drug targets for BRCA-driven cancer uncovered

by Brigham and Women's HospitalCredit: CC0 Public DomainBRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes h
Oncology March 30,2024
New drug targets for BRCA-driven cancer uncovered

New drug targets for BRCA-driven cancer uncovered

by Brigham and Women's HospitalCredit: CC0 Public DomainBRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes h
Oncology March 30,2024
ASCO endorses SIO guideline for integrative Tx in breast cancer

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat
Oncology March 30,2024
ASCO endorses SIO guideline for integrative Tx in breast cancer

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat
Oncology March 30,2024
Advancing neuropathology with AI-driven classification of diffuse gliomas

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse
Oncology March 30,2024
Advancing neuropathology with AI-driven classification of diffuse gliomas

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse
Oncology March 30,2024
ASCO: liquid biopsy accurate for detecting colorectal cancer

ASCO: liquid biopsy accurate for detecting colorectal cancer

(HealthDay)—Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer (CRC), according to a study presented at the American Society of C
Oncology March 30,2024
ASCO: liquid biopsy accurate for detecting colorectal cancer

ASCO: liquid biopsy accurate for detecting colorectal cancer

(HealthDay)—Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer (CRC), according to a study presented at the American Society of C
Oncology March 30,2024
App an effective tool to record sun exposure

App an effective tool to record sun exposure

by Queensland University of TechnologyCredit: Queensland University of TechnologyA smartphone app is an accessible tool that reliably measures the amount of exposure to the sun's skin-damagin
Oncology March 30,2024
App an effective tool to record sun exposure

App an effective tool to record sun exposure

by Queensland University of TechnologyCredit: Queensland University of TechnologyA smartphone app is an accessible tool that reliably measures the amount of exposure to the sun's skin-damagin
Oncology March 30,2024
BRCA1/2 genetic testing recommendations still leave issues unresolved

BRCA1/2 genetic testing recommendations still leave issues unresolved

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe U.S. Preventive Services Task Force (USPSTF) has released a new Recommendation Statement forBRCA
Oncology March 30,2024
BRCA1/2 genetic testing recommendations still leave issues unresolved

BRCA1/2 genetic testing recommendations still leave issues unresolved

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe U.S. Preventive Services Task Force (USPSTF) has released a new Recommendation Statement forBRCA
Oncology March 30,2024
ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin
Oncology March 30,2024
ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin
Oncology March 30,2024
ASCO: undertreatment seen for women with head and neck cancer

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi
Oncology March 30,2024
ASCO: undertreatment seen for women with head and neck cancer

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi
Oncology March 30,2024
ASCO: low-dose chemo benefits advanced gastroesophageal cancer

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s
Oncology March 30,2024
ASCO: low-dose chemo benefits advanced gastroesophageal cancer

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com